The role of interim 18 F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma

European Journal of Nuclear Medicine and Molecular Imaging
Christos SachpekidisAntonia Dimitrakopoulou-Strauss

Abstract

The aim of the present study was to assess the value of interim 18F-FDG PET/CT performed after the first two cycles of ipilimumab treatment in the prediction of the final clinical response to this type of immunotherapy. The study group comprised 41 patients with unresectable metastatic melanoma scheduled for ipilimumab therapy. Whole-body 18F-FDG PET/CT was performed before the start of ipilimumab treatment (baseline PET/CT) and after the initial two cycles of ipilimumab treatment (interim PET/CT). Evaluation of patient response to treatment was based on the European Organization for Research and Treatment of Cancer (EORTC) 1999 criteria for PET as well as the recently proposed PET Response Evaluation Criteria for Immunotherapy (PERCIMT). The patients' best clinical response, assessed at a median of 21.4 months (range 6.3-41.9 months) was used as reference. According to their best clinical response, the patients were divided into two groups: those showing clinical benefit (CB) including stable disease, partial response and complete response (31 patients), and those showing no clinical benefit (no-CB including progressive disease (10 patients). According to the EORTC criteria, interim PET/CT demonstrated progressive metabolic di...Continue Reading

References

Jan 1, 1981·Cancer·A B MillerA Winkler
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H YoungP Price
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg
Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie G DowneySteven A Rosenberg
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·F Stephen HodiGlenn Dranoff
Nov 15, 2008·Annual Review of Immunology·Michael Dougan, Glenn Dranoff
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jun 24, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Richard L WahlMartin A Lodge
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
May 10, 2013·Clinical Nuclear Medicine·Phillip J KooRene Gonzalez
Jun 8, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mizuki NishinoF Stephen Hodi
Jul 12, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Laura GilardiGiovanni Paganelli
Nov 2, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Christos SachpekidisJessica C Hassel
Aug 12, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Victoria L Chiou, Mauricio Burotto
Mar 10, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F Stephen HodiJedd D Wolchok
Jul 1, 2009·PET Clinics·Susan BahlBrian J Czerniecki
Nov 8, 2016·Academic Radiology·Jason W WachsmannFangyu Peng
Mar 9, 2017·The Lancet Oncology·Lesley SeymourUNKNOWN RECIST working group
Apr 1, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Steve Y ChoRichard L Wahl
Aug 24, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Ferdinand SeithNina Schwenzer
Nov 11, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Hoda AnwarAntonia Dimitrakopoulou-Strauss

❮ Previous
Next ❯

Citations

Jul 6, 2019·Journal of Animal Physiology and Animal Nutrition·Yong WangDexin Qiu
Feb 28, 2020·The British Journal of Radiology·Nemi GandyTara D Barwick
Nov 22, 2019·Current Radiopharmaceuticals·Angelo Castello, Egesta Lopci
Apr 28, 2020·European Journal of Nuclear Medicine and Molecular Imaging·Amir IravaniRodney J Hicks
Feb 29, 2020·The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica·Angelo Castello, Egesta Lopci
Mar 29, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·C MesnardB Dréno
Nov 28, 2018·Cancer Immunology, Immunotherapy : CII·Christos SachpekidisAntonia Dimitrakopoulou-Strauss
Oct 7, 2018·European Journal of Nuclear Medicine and Molecular Imaging·Nicolas AideEgesta Lopci
Apr 17, 2020·European Journal of Nuclear Medicine and Molecular Imaging·Ryusuke NakamotoBenjamin Lewis Franc
Jul 10, 2019·The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica·Angelo Castello, Egesta Lopci
May 28, 2020·Cancers·Stefano FregaLaura Evangelista
Feb 23, 2020·The International Journal of Biological Markers·Laura Evangelista
May 21, 2020·European Journal of Nuclear Medicine and Molecular Imaging·Antonia Dimitrakopoulou-StraussChristos Sachpekidis
Oct 10, 2020·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Roberto García-FigueirasJoan C Vilanova
Dec 5, 2020·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Larissa B CostaCarlos A Buchpiguel
Nov 18, 2020·European Radiology Experimental·Marcus UnterrainerClemens C Cyran
Dec 19, 2020·European Journal of Nuclear Medicine and Molecular Imaging·Christos SachpekidisAntonia Dimitrakopoulou-Strauss
Mar 14, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Min ChenJianghong Rao
Mar 25, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Chukwuka EzeMarcus Unterrainer
Jun 26, 2020·International Journal of Radiation Oncology, Biology, Physics·Robert R FlavellSue S Yom
Sep 5, 2019·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Hanna SaadaniMarcel P M Stokkel
Dec 7, 2019·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Giovanni RossiFrancesco Grossi
Nov 29, 2020·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Narjess AyatiAndrew M Scott
Aug 4, 2021·Trends in Endocrinology and Metabolism : TEM·Yi LiuShuang Tang
Aug 17, 2021·Radiologic Clinics of North America·Katherine A ZukotynskiVictor H Gerbaudo
Aug 17, 2021·Radiologic Clinics of North America·Chadwick L WrightMichael V Knopp
Aug 17, 2021·Radiologic Clinics of North America·Osigbemhe Iyalomhe, Michael D Farwell
Mar 24, 2020·Chemical Reviews·Weijun WeiWeibo Cai
Sep 9, 2021·EJNMMI Research·Christos SachpekidisAntonia Dimitrakopoulou-Strauss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

© 2022 Meta ULC. All rights reserved